ByTrending Posts
How Google Med-Gemini’s “Basilar Ganglia” AI Hallucination Signal a Wake-Up Call for…
Key Highlights: AI Hallucination: The “Basilar Ganglia” ErrorGoogle’s Med-Gemini suite, designed to summarize health data and generate radiology…
Can XtalPi & DoveTree’s $6 Billion AI Partnership…
Key Highlights: Strategic Overview: Industry’s Largest AI-Pharma CollaborationThis collaboration—one of the biggest in AI-driven drug discovery—combines XtalPi’s robust…
Will CMS’s 2026 WISeR AI Pilot Shift Traditional…
Key Highlights: AI-Powered Prior Authorization: New Model and ScopeCMS’s WISeR (Wasteful and Inappropriate Service Reduction) program introduces AI…
Can Harvard’s FaceAge and Emerging AI Facial Recognition…
Key Highlights: AI Facial Recognition as a Medical BiomarkerDeveloped at Harvard Medical School, the FaceAge algorithm analyzes photos…
How Will BioNTech’s Patent Settlement Impact the Future…
Key Highlights Resolving Patent Litigation and Securing LicensesBioNTech SE and Pfizer reached agreements with CureVac N.V. and GlaxoSmithKline…
Could Eli Lilly’s AI-Driven Innovation Accelerate Biopharma Growth…
Key Highlights Robust Revenue Growth Powered by AI-Driven ProductsIn Q2 2025, Eli Lilly delivered impressive top-line performance with…
Could Chai’s $70 Million OpenAI-Backed Funding Propel the Next Leap…
Key Highlights Breakthrough Funding and Industry BackingThe Series A round brings Chai Discovery’s total capital to $100 million,…
Is Illinois’ Ban on AI in Mental Healthcare a Turning Point for…
Key Highlights Background and Impetus for the BanDriven by incidents where AI chatbots posed risks—including cases suggesting harmful…
Can Zimmer Biomet’s $177 Million AI-Driven Acquisition of…
Key Highlights Strategic Acquisition Enhances Zimmer Biomet’s Robotics LeadershipZimmer Biomet’s acquisition of Monogram Technologies, announced in July 2025,…
Trending Posts
Latest Stories
Can Amgen’s 2025 Approvals and Launches Strengthen Its Oncology, Cardiovascular, and Bone Health Leadership Into 2026?
Global | January 2026 — Amgen Inc. achieved key milestones in 2025, marked by multiple…
Can GSK’s 2025 Approvals and Launches Strengthen Its Vaccines, Respiratory, and Immunology Leadership Into 2026?
Global | January 2026 — GlaxoSmithKline PLC (GSK) achieved key milestones in 2025, with multiple…
Can AstraZeneca’s 2025 Launches and Approvals Strengthen Its Oncology, Cardiovascular, and Respiratory Leadership Into 2026?
Global | January 2026 — AstraZeneca PLC achieved significant milestones in 2025, marked by multiple…
Can Novo Nordisk’s 2025 Diabetes, Obesity, and Rare Disease Launches Drive Sustainable Growth Into 2026?
Global | January 2026 — Novo Nordisk A/S continued to reinforce its leadership in diabetes,…
Gallery
